Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference

COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.

Non-Invasive Prenatal Testing Market is expected to generate a revenue of USD 9.83 Billion by 2031, Globally, at 17.01% CAGR: Verified Market Research®

Verified Market Research® is pleased to announce the release of its latest market research report on the “Non-Invasive Prenatal Testing Market – Trends, Opportunities, and Forecasts”, offering ...

Next-Generation Sequencing (NGS) Services Market is expected to generate a revenue of USD 18.35 Billion by 2031, Globally, at 21.25% CAGR: Verified Market Research®

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Next-Generation ...